person · Reporting owner
Worthington Gajus Vincent
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
STANDARD BIOTOOLS INC.
Report date October 19, 2016 · Filed October 21, 2016
Section 16 reporting ended · disclosed 2016-10-21. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $47.55 · Expires 2024-03-14 | Direct | 0 |
Reported balance
After 2016-10-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2016-10-19 · Disposition to issuer · Disposed 65,000 · Balance 0 F2: The option was cancelled by mutual agreement of the reporting person and Fluidigm Corporation. As consideration for the cancellation of the options, the reporting person entered into a Separation Agreement and Release that will be filed as Exhibit 99.1 to Fluidigm Corporation's Current Report on Form 8-K on October 24, 2016. F1: 1/48th of the shares subject to the Option vested monthly beginning January 1, 2014. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $41.14 · Expires 2025-03-12 | Direct | 0 |
Reported balance
After 2016-10-19 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2016-10-19 · Disposition to issuer · Disposed 31,110 · Balance 0 F2: The option was cancelled by mutual agreement of the reporting person and Fluidigm Corporation. As consideration for the cancellation of the options, the reporting person entered into a Separation Agreement and Release that will be filed as Exhibit 99.1 to Fluidigm Corporation's Current Report on Form 8-K on October 24, 2016. F3: 1/48th of the shares subject to the Option vested monthly beginning January 1, 2015. |
Filing footnotes · ownership attribution and instrument terms
F1: 1/48th of the shares subject to the Option vested monthly beginning January 1, 2014.
F2: The option was cancelled by mutual agreement of the reporting person and Fluidigm Corporation. As consideration for the cancellation of the options, the reporting person entered into a Separation Agreement and Release that will be filed as Exhibit 99.1 to Fluidigm Corporation's Current Report on Form 8-K on October 24, 2016.
F3: 1/48th of the shares subject to the Option vested monthly beginning January 1, 2015.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 19, 2016 Filed Oct 21, 2016 23:55 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 31,110 | Not disclosed Strike: $41.14 | Not disclosed |
DisclosureSEC source: 0001162194-16-000244 · wf-form4_147709411455580.xml · derivative · entry 2 Worthington Gajus Vincent · CIK 0001435768 · Former CEO & Former Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 31,110 shares Expires 2025-03-12 F2 · price: The option was cancelled by mutual agreement of the reporting person and Fluidigm Corporation. As consideration for the cancellation of the options, the reporting person entered into a Separation Agreement and Release that will be filed as Exhibit 99.1 to Fluidigm Corporation's Current Report on Form 8-K on October 24, 2016. F3 · derivative.exercise_date: 1/48th of the shares subject to the Option vested monthly beginning January 1, 2015. Read SEC document |
| October 19, 2016 Filed Oct 21, 2016 23:55 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 65,000 | Not disclosed Strike: $47.55 | Not disclosed |
DisclosureSEC source: 0001162194-16-000244 · wf-form4_147709411455580.xml · derivative · entry 1 Worthington Gajus Vincent · CIK 0001435768 · Former CEO & Former Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 65,000 shares Expires 2024-03-14 F2 · price: The option was cancelled by mutual agreement of the reporting person and Fluidigm Corporation. As consideration for the cancellation of the options, the reporting person entered into a Separation Agreement and Release that will be filed as Exhibit 99.1 to Fluidigm Corporation's Current Report on Form 8-K on October 24, 2016. F1 · derivative.exercise_date: 1/48th of the shares subject to the Option vested monthly beginning January 1, 2014. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.